Dr. Ren leads department-wide and university-wide efforts in high-throughput sequencing, with a particular focus on RNA sequencing (RNA-Seq), exome sequencing (Exome-Seq), and single-cell sequencing (Single Cell-Seq) to advance precision medicine and molecular diagnostics. His research also explores innovative cancer therapies, including antibody-based treatments and the therapeutic modification of messenger RNA (mRNA) to target cancer at the molecular level.
1.He DM, Ren BG and Luo JH. (2017) Oncogenic activity of amplified miniate chromosome maintenance 8 in human malignancies. Oncogene, Jun 22;36(25):3629-3639
2. Yan P. Yu, Chi Song, George Tseng, Baoguo Ren, William LaFramboise, George Michalopoulos, Joel Nelson and Jian-Hua Luo(2012). Genome abnormalities precede prostate cancer and predict clinical relapse. American Journal of Pathology, 180, 2240-8.
3. Jinbo.Gao, Baoguo Ren J.H.Yim et al. Cell Death and Differentiation in April, 2010.
4. Shi YK, Yu YP, Zhu ZH, Han YC, Ren B, Nelson JB, Luo JH. MCM7 Interacts with Androgen Receptor. Am J Pathol. 2008 Dec; 173(6):1758-1767. Epub 2008 Nov6
5. Baoguo Ren, Yan P. Yu, George C. Tseng, Chuanyue Wu, Ka Chen, Uma N. Rao, Joel Nelson, George K. Michalopoulos and Jian-Hua Luo (2007). Analysis of Integrin α7 Mutations in Prostate Cancer, Liver Cancer, Glioblastoma Multiforme, and Leiomyosarcoma. Journal of National Cancer Institute, 99, 868-880
6. Jian-Hua Luo, Baoguo Ren, Sergei Keryanov, George K. Michalopoulos. Liver Biology and Pathobiology Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology. 2006 V44 (4)1012-1024